3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Neoplasms
518
Breast Neoplasms
461
Lung Neoplasms
256
Prostatic Neoplasms
235
Colorectal Neoplasms
218
Carcinoma, Non-Small-Cell Lung
188
Pancreatic Neoplasms
157
Stomach Neoplasms
140
Carcinoma, Hepatocellular
136
Ovarian Neoplasms
120
Multiple Myeloma
98
Melanoma
95
Head and Neck Neoplasms
95
Esophageal Neoplasms
94
Urinary Bladder Neoplasms
87
Disease
87
Lymphoma
79
Uterine Cervical Neoplasms
78
Hematologic Neoplasms
77
Liver Neoplasms
76
Brain Neoplasms
76
Endometrial Neoplasms
73
Neoplasm Metastasis
65
Leukemia, Myeloid, Acute
65
Colonic Neoplasms
61
Rectal Neoplasms
60
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Leukemia
54
Sarcoma
53
Glioma
53
Interventions
darolutamide
2
Docetaxel
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Observational
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Clear all
NCT07395804
2026-05-26
23146
Bayer
Recruiting
500 enrolled
NCT06661122
2026-05-19
HAYATE
Bayer
Recruiting
100 enrolled